Advanced search×

[25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease].

C C García-Cantón, E E Bosch, I I Auyanet, A A Ramírez, P P Rossique, C C Culebras, A A Sánchez, A A Toledo, M M Lago, Noemí N Esparza, and María Dolores MD Checa

Nefrologia 30(4):435-42 (2010) PMID 20651885

Decreased 25 hydroxyvitamin D serum levels have been related to an increase in cardiovascular morbility and mortality in both general population and chronic kidney disease patients. The aim of this study was to evaluate the relationship between 25 hydroxyvitamin D serum level, cardiovascular risk factors and previous established cardiovascular disease in a group of patients with advanced chronic kidney disease.

DOI: 10.3265/Nefrologia.pre2010.Mar.10288
Version: za2963e q8zab q8zb0 q8zc5 q8zd5 q8ze6 q8zf3 q8zg6

Similar articles you may find interesting…

  1. Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Progra...
    Andrew S Bomback, Abhijit V Kshirsagar, ... George L Bakris

    Am J Kidney Dis 55(3 Suppl 2):0 (2010) PMID 20172446

    Obesity and metabolic syndrome may be heterogeneous disease states in African Americans and whites, possibly explaining differences in long-term kidney and cardiovascular outcomes. Copyright (c) 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved....
  2. [Effects of SERMs on bone health. The potential of SERM in the care of chronic kidney disease-mineral bone and disorders].
    Takayuki T Hamano

    Clin Calcium 20(3):373-9 (2010) PMID 20190367

    The umbrella concept chronic kidney disease-mineral bone and disorders (CKD-MBD) has been developed these days, which includes vascular calcification, laboratory abnormalities, and bone abnormalities. Given the high prevalence of CKD stage 3 in the patients with osteoporosis and the high risk of fra...
  3. The relationship between circulating fibroblast growth factor 23 and bone metabolism factors in Korean hemodialysis patients.
    So-Youn SY Park, Kyung-Hwan KH Jeong, ... Tae-Won TW Lee

    Audio, Transactions of the IRE Profession... 14(3):239-43 (2010) PMID 20376517

    FGF-23 levels were positively associated with serum phosphate levels but were not correlated with BMD. The only factors affecting log(10)FGF-23 were the serum calcium phosphate product and K (t)/V. These findings suggest that FGF-23 may have no direct effect on bone mineralization, and further studi...